Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
DOAC’s nog steeds op kop in uitgaven top 10
jun 2023 | Benigne hematologie